Forward Ventures

Forward Ventures is a prominent venture capital firm specializing in life sciences, primarily focusing on biopharmaceutical therapeutics. Since its founding in 1990, the firm has invested in over 60 companies across various stages of development, managing more than $500 million in capital. Their portfolio includes investments in biotechnology, health tech, and AI sectors, with a geographical focus on the United States and Europe.

The firm's investment strategy encompasses a wide range of stages, from seed to late-stage investments, including Series A, Series B, growth, late stage, pre-IPO, buyout, turnaround, and distressed opportunities. This comprehensive approach allows Forward Ventures to support companies at different phases of their development, providing tailored capital and expertise to foster growth and innovation.

With a team of experienced professionals, Forward Ventures leverages its internal expertise alongside portfolio company founders and management to generate strong returns for all stakeholders. Their extensive experience in entrepreneurship, venture capital, biological sciences, operations, and corporate management enables them to identify and nurture high-potential startups, driving value creation and positive impact in the life sciences sector.